|
Volumn 66, Issue 2-3, 2002, Pages 333-341
|
Endocannabinoids and the gut
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 ARACHIDONOYLGLYCEROL;
ANANDAMIDE;
CANNABINOID 1 RECEPTOR;
CANNABINOID DERIVATIVE;
CANNABINOID RECEPTOR AGONIST;
CANNABINOID RECEPTOR ANTAGONIST;
RIMONABANT;
VANILLOID RECEPTOR;
AMIDE;
ARACHIDONIC ACID DERIVATIVE;
CANNABINOID;
CANNABINOID RECEPTOR;
DRUG RECEPTOR;
ENDOCANNABINOID;
ICOSANOID;
DRUG RECEPTOR BINDING;
GUINEA PIG;
ILEUM;
INTESTINE;
INTESTINE INNERVATION;
INTESTINE MOTILITY;
METABOLISM;
MOUSE;
NONHUMAN;
PERISTALSIS;
PRIORITY JOURNAL;
RAT;
REVIEW;
ANIMAL;
ANTIBODY SPECIFICITY;
DIGESTIVE SYSTEM;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
GASTROINTESTINAL MOTILITY;
HUMAN;
PATHOPHYSIOLOGY;
SIGNAL TRANSDUCTION;
SYNAPTIC TRANSMISSION;
TRANSPORT AT THE CELLULAR LEVEL;
CAVIA PORCELLUS;
SUS SCROFA;
ANIMALS;
ARACHIDONIC ACIDS;
BIOLOGICAL TRANSPORT;
CANNABINOIDS;
DIGESTIVE SYSTEM;
EICOSANOIDS;
ENDOCANNABINOIDS;
GASTROINTESTINAL MOTILITY;
HUMANS;
ORGAN SPECIFICITY;
POLYUNSATURATED ALKAMIDES;
RECEPTORS, CANNABINOID;
RECEPTORS, DRUG;
SIGNAL TRANSDUCTION;
SYNAPTIC TRANSMISSION;
|
EID: 0036019418
PISSN: 09523278
EISSN: None
Source Type: Journal
DOI: 10.1054/plef.2001.0345 Document Type: Article |
Times cited : (55)
|
References (71)
|